Zacks Investment Research
10 Mar 2026, 14:55 UTC · 30w ago
Impact · against what's priced in
ArriVent BioPharma shows strong bullish signals from analysts, including a significant mean price target upside of 70.4% and positive earnings revisions. These fundamental indicators suggest potential growth beyond current market levels.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a mean short-term price target of $42.27 for ArriVent BioPharma (AVBP), suggesting a potential 70.4% upside from its current price of $24.81.
So whatA strong consensus among 11 analysts for significant upside typically attracts buyers and increases bullish sentiment for the specific ticker.
More positive than 93% of claims this week
There is a positive trend in earnings estimate revisions for ArriVent BioPharma, indicating analysts expect better earnings than previously predicted.
Continue reading
5 related stories
Analysts maintain a mean price target of $42.27, suggesting a 70.4% upside from the current price of $24.81, supported by a tight standard deviation of $5.39 across 11 estimates.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 79% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The stock has gained 16% recently and has a mean analyst price target indicating 70.4% upside potential with positive earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
18h ago
−32.6%
Price is moving against the score
$16.73 vs $24.81 close before publication (Mar 9) · not market-adjusted
AVBP chart →
